BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 31467028)

  • 1. Unique genetic basis of the distinct antibiotic potency of high acetic acid production in the probiotic yeast
    Offei B; Vandecruys P; De Graeve S; Foulquié-Moreno MR; Thevelein JM
    Genome Res; 2019 Sep; 29(9):1478-1494. PubMed ID: 31467028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New biomarkers underlying acetic acid tolerance in the probiotic yeast Saccharomyces cerevisiae var. boulardii.
    Samakkarn W; Vandecruys P; Moreno MRF; Thevelein J; Ratanakhanokchai K; Soontorngun N
    Appl Microbiol Biotechnol; 2024 Jan; 108(1):153. PubMed ID: 38240846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Mutation in
    Liu JJ; Zhang GC; Kong II; Yun EJ; Zheng JQ; Kweon DH; Jin YS
    Appl Environ Microbiol; 2018 May; 84(10):. PubMed ID: 29523547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing probiotic impact: engineering
    de Carvalho BT; Subotić A; Vandecruys P; Deleu S; Vermeire S; Thevelein JM
    Appl Environ Microbiol; 2024 May; ():e0032524. PubMed ID: 38752748
    [No Abstract]   [Full Text] [Related]  

  • 5. Production of neoagarooligosaccharides by probiotic yeast Saccharomyces cerevisiae var. boulardii engineered as a microbial cell factory.
    Jin Y; Yu S; Liu JJ; Yun EJ; Lee JW; Jin YS; Kim KH
    Microb Cell Fact; 2021 Aug; 20(1):160. PubMed ID: 34407819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yeasts as probiotics: Mechanisms, outcomes, and future potential.
    Sen S; Mansell TJ
    Fungal Genet Biol; 2020 Apr; 137():103333. PubMed ID: 31923554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique Probiotic Properties and Bioactive Metabolites of Saccharomyces boulardii.
    Fu J; Liu J; Wen X; Zhang G; Cai J; Qiao Z; An Z; Zheng J; Li L
    Probiotics Antimicrob Proteins; 2023 Aug; 15(4):967-982. PubMed ID: 35608794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth, survival, and metabolic activities of probiotics Lactobacillus rhamnosus GG and Saccharomyces cerevisiae var. boulardii CNCM-I745 in fermented coffee brews.
    Chan MZA; Toh M; Liu SQ
    Int J Food Microbiol; 2021 Jul; 350():109229. PubMed ID: 34023682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcoholic and non-alcoholic rosé wines made with Saccharomyces cerevisiae var. boulardii probiotic yeast.
    Mulero-Cerezo J; Tuñón-Molina A; Cano-Vicent A; Pérez-Colomer L; Martí M; Serrano-Aroca Á
    Arch Microbiol; 2023 Apr; 205(5):201. PubMed ID: 37081186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Saccharomyces cerevisiae var. boulardii in co-fermentations with S. cerevisiae for the production of craft beers with potential healthy value-added.
    Capece A; Romaniello R; Pietrafesa A; Siesto G; Pietrafesa R; Zambuto M; Romano P
    Int J Food Microbiol; 2018 Nov; 284():22-30. PubMed ID: 29990636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-promoting properties of
    Ansari F; Alian Samakkhah S; Bahadori A; Jafari SM; Ziaee M; Khodayari MT; Pourjafar H
    Crit Rev Food Sci Nutr; 2023; 63(4):457-485. PubMed ID: 34254862
    [No Abstract]   [Full Text] [Related]  

  • 12. Antioxidant properties and global metabolite screening of the probiotic yeast Saccharomyces cerevisiae var. boulardii.
    Datta S; Timson DJ; Annapure US
    J Sci Food Agric; 2017 Jul; 97(9):3039-3049. PubMed ID: 27868205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome-wide differences between Saccharomyces cerevisiae and Saccharomyces cerevisiae var. boulardii: Clues on host survival and probiotic activity based on promoter sequence variability.
    Pais P; Oliveira J; Almeida V; Yilmaz M; Monteiro PT; Teixeira MC
    Genomics; 2021 Mar; 113(2):530-539. PubMed ID: 33482324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Saccharomyces cerevisiae var. boulardii in food processing: a review.
    Lazo-Vélez MA; Serna-Saldívar SO; Rosales-Medina MF; Tinoco-Alvear M; Briones-García M
    J Appl Microbiol; 2018 Oct; 125(4):943-951. PubMed ID: 29961970
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Durmusoglu D; Al'Abri IS; Collins SP; Cheng J; Eroglu A; Beisel CL; Crook N
    ACS Synth Biol; 2021 May; 10(5):1039-1052. PubMed ID: 33843197
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular tools for differentiating probiotic and clinical strains of Saccharomyces cerevisiae.
    Posteraro B; Sanguinetti M; Romano L; Torelli R; Novarese L; Fadda G
    Int J Food Microbiol; 2005 Sep; 103(3):295-304. PubMed ID: 16099314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel insights in genetic transformation of the probiotic yeast Saccharomyces boulardii.
    Douradinha B; Reis VC; Rogers MB; Torres FA; Evans JD; Marques ET
    Bioengineered; 2014; 5(1):21-9. PubMed ID: 24013355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungemia following Saccharomyces cerevisiae var. boulardii probiotic treatment in an elderly patient.
    Landaburu MF; López Daneri GA; Relloso S; Zarlenga LJ; Vinante MA; Mujica MT
    Rev Argent Microbiol; 2020; 52(1):27-30. PubMed ID: 31262611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiome Engineering Using Probiotic Yeast:
    Kim J; Atkinson C; Miller MJ; Kim KH; Jin YS
    Microbiol Spectr; 2023 Aug; 11(4):e0078023. PubMed ID: 37436157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strain engineering and metabolic flux analysis of a probiotic yeast Saccharomyces boulardii for metabolizing L-fucose, a mammalian mucin component.
    Kim J; Cheong YE; Yu S; Jin YS; Kim KH
    Microb Cell Fact; 2022 Oct; 21(1):204. PubMed ID: 36207743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.